We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Compound Demonstrates Potential as Broad-Spectrum Antiviral Drug

By LabMedica International staff writers
Posted on 12 Apr 2018
Print article
Image: Under a very-high magnification, this digitally colorized scanning electron micrograph (SEM) depicts a number of filamentous Ebola virus particles (red) that had budded from the surface of a VERO cell (brown) of the African green monkey kidney epithelial cell line (Photo courtesy of the [U.S.] National Institute of Allergy and Infectious Diseases).
Image: Under a very-high magnification, this digitally colorized scanning electron micrograph (SEM) depicts a number of filamentous Ebola virus particles (red) that had budded from the surface of a VERO cell (brown) of the African green monkey kidney epithelial cell line (Photo courtesy of the [U.S.] National Institute of Allergy and Infectious Diseases).
A team of molecular biologists identified a potent drug candidate with specificity towards especially deadly viruses such as Ebola virus and Marburg virus.

Ebola virus (EBOV), a member of the filovirus family, is an enveloped, single-stranded RNA virus that causes severe disease in humans. While there are no internationally approved therapies for EBOV, it is known that EBOV RNA synthesis is carried out by a virus-encoded complex with RNA-dependent RNA polymerase activity that is required for viral propagation. This complex and its activities are therefore potential antiviral targets.

To exploit this possible weakness in the virus, investigators at Georgia State University (Atlanta, USA) used a previously established 384-well microplate format minigenome assay (MGA) of EBOV RNA synthesis to screen a library of 200,000 small molecule compounds to identify potential inhibitors of Ebola virus RNA synthesis.

The investigators reported in the February 2018 issue of the journal Antiviral Research that the screen identified 56 hits that inhibited EBOV MGA activity by more than 70% while exhibiting less than 20% cell cytotoxicity. Inhibitory chemical scaffolds included angelicin derivatives, derivatives of the antiviral compound GSK983, and benzoquinolines. Benzoquinolines are isomeric compounds (such as 5,6-benzoquinoline and 7,8-benzoquinoline) in which a benzene ring is fused to that of a quinoline molecule; their derivatives are used in the preparation of pharmaceuticals and dyes.

Structure-activity relationship (SAR) studies of the benzoquinoline scaffold produced nearly 50 analogs and led to identification of an optimized compound, SW456, with antiviral activity against infectious EBOV in cell culture. The compound was also active against a MGA for another deadly filovirus, Marburg virus. Furthermore, this compound also exhibited antiviral activity towards a negative-sense RNA virus from the rhabdovirus family, vesicular stomatitis virus, and a positive-sense RNA virus, Zika virus.

Overall, the data accumulated during this study demonstrated the potential of the EBOV MGA to identify anti-EBOV compounds and identified the potential broad-spectrum antiviral properties of the benzoquinoline series.

"This work provides a foundation for the development of novel antiviral agents to combat Ebola virus," said senior author Dr. Christopher Basler, professor of microbial pathogenesis and biomedical sciences at Georgia State University.

Related Links:
Georgia State University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.